U.S. RESEARCH ROUNDUP- Brown-Forman, Chord Energy, Olaplex Holdings

Reuters03-27 15:54
U.S. RESEARCH ROUNDUP- Brown-Forman, Chord Energy, Olaplex Holdings

March 27 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Brown-Forman, Chord Energy and Olaplex Holdings on Friday.

HIGHLIGHTS

* Argan Inc AGX.N: JP Morgan raises target price to $550 from $370

* Brown-Forman Corp BFb.N: JP Morgan raises to neutral from underweight

* Chord Energy Corp CHRD.O: Gerdes Energy Research cuts to neutral from buy

* Cintas Corp CTAS.O: Jefferies cuts target price to $200 from $210

* Olaplex Holdings Inc OLPX.O: Canaccord Genuity cuts to hold from buy

Following is a summary of research actions on U.S. companies reported by Reuters on Friday. Stock entries are in alphabetical order.

* Alphabet Inc. GOOGL.O: Wells Fargo raises target price to $397 from $387

* Argan Inc AGX.N: JP Morgan raises target price to $550 from $370

* Argan Inc AGX.N: JP Morgan raises to overweight from neutral

* Ataibeckley Inc ATAI.O: Deutsche Bank initiates with buy rating and target price $12

* Automatic Data ProcessingADP.O: Wells Fargo cuts target price to $214 from $262

* Bally's Corp BALY.N: Truist Securities cuts target price to $13 from $18

* Bank of America BAC.N: Oppenheimer cuts target price to $58 from $63

* Bioage Labs Inc BIOA.O: Needham initiates coverage with buy rating; target price $50

* Bitgo Holdings Inc BTGO.N: Rosenblatt Securities cuts target price to $15 from $17

* Brown-Forman Corp BFb.N: Citigroup raises target price to $28 from $24

* Brown-Forman Corp BFb.N: Citigroup raises to neutral from sell

* Brown-Forman Corp BFb.N: JP Morgan raises target price to $27 from $25

* Brown-Forman Corp BFb.N: JP Morgan raises to neutral from underweight

* Carnival Corp CCL.N: Mizuho raises target price to $39 from $38

* Chord Energy Corp CHRD.O: Gerdes Energy Research cuts target price by $5 to $155

* Chord Energy Corp CHRD.O: Gerdes Energy Research cuts to neutral from buy

* Cintas Corp CTAS.O: Jefferies cuts target price to $200 from $210

* Citigroup Inc. C.N: Oppenheimer cuts target price to $132 from $144

* Commercial Metals Company CMC.N: Wells Fargo cuts target price to $77 from $80

* Conocophillips COP.N: Gerdes Energy Research cuts to neutral from buy

* EOG Resources Inc EOG.N: Raymond James raises target price to $185 from $157

* Fiserv Inc. FISV.O: Wells Fargo cuts target price to $62 from $72

* Fox Corporation FOXA.O: Wells Fargo cuts target price to $67 from $75

* FuboTV Inc FUBO.N: Needham cuts target price to $15 from $36

* Gartner Inc. IT.N: Wells Fargo cuts target price to $140 from $150

* Generac Holdings Inc GNRC.N: Barclays raises target price to $228 from $213

* Halliburton Co HAL.N: JP Morgan raises target price to $40 from $35

* Immix Biopharma Inc. IMMX.O: H.C. Wainwright raises target price to $15 from $12

* Iperionx Ltd IPX.O: BTIG initiates coverage with buy rating; target price $40

* Kodiak Sciences Inc KOD.O: Jefferies raises target price to $56 from $39

* Kodiak Sciences Inc. KOD.O: H.C. Wainwright raises target price to $58 from $38

* Kyivstar Group Ltd KYIV.O: Benchmark initiates coverage with buy rating; target $20

* LB Pharmaceuticals Inc LBRX.O: Stifel raises target price to $40 from $35

* Legence Corp LGN.O: BTIG raises target price to $75 from $45

* Masimo Corp MASI.O: Raymond James cuts to market perform from outperform

* MeiraGTx Holdings Plc MGTX.O: Piper Sandler cuts target price to $26 from $30

* National Health Investors Inc. NHI.N: Wells Fargo raises target to $86 from $85

* Netflix, Inc. NFLX.O: Oppenheimer raises target price to $135 from $125

* Occidental Petroleum Corp OXY.N: Gerdes Energy Research cuts to neutral from buy

* Olaplex Holdings Inc OLPX.O: Canaccord Genuity cuts to hold from buy

* Olaplex Holdings Inc OLPX.O: Telsey Advisory Group raises target to $2.06 from $2

* Oxford Industries Inc OXM.N: Telsey Advisory Group cuts target price to $36 from $40

* Oxford Industries Inc OXM.N: Truist Securities cuts target price to $32 from $38

* Phathom Pharmaceuticals Inc. PHAT.O: Barclays raises target price to $18 from $16

* Phathom Pharmaceuticals Inc. PHAT.O: Barclays raises to overweight from equal-weight

* Planet Labs PL.N: Deutsche Bank raises target price to $38 from $17

* PNC Financial Services Group PNC.N: Oppenheimer cuts target price to $263 from $284

* Primo Brands Corp PRMB.N: Jefferies raises target price to $25 from $24

* Primo Brands Corp PRMB.N: Jefferies raises to buy from hold

* SPX Technologies Inc SPXC.N: Truist Securities raises to buy from hold

* Terns Pharmaceuticals Inc TERN.O: Mizuho cuts to neutral from outperform

* Terns Pharmaceuticals Inc TERN.O: Mizuho cuts target price to $53 from $54

* the Walt Disney Company DIS.N: Deutsche Bank cuts target price to $132 from $135

* the Walt Disney Company DIS.N: Wells Fargo cuts target price to $148 from $150

* Tripadvisor Inc TRIP.O: BofA Global Research raises to buy from neutral

* Tripadvisor Inc TRIP.O: BofA Global Research raises price objective to $15 from $14

* U.S. Bancorp USB.N: Oppenheimer cuts target price to $71 from $77

* Unity Software Inc U.N: Morgan Stanley raises target price to $32 from $30

* Venture Global Inc VG.N: JP Morgan raises target price to $19 from $11

* Viasat Inc VSAT.O: Needham raises target price to $58 from $45

* Vital Farms Inc VITL.O: Telsey Advisory Group cuts target price to $26 from $35

(Compiled by Bengaluru Newsroom)

((Diaries@thomsonreuters.com))

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment